Improved brain perfusion after electrical cardioversion of atrial fibrillation
Abstract Aims Atrial fibrillation (AF) has been associated with reduced brain volume, cognitive impairment, and reduced cerebral blood flow. The causes of reduced cerebral blood flow in AF are unknown, but no reduction was seen in individuals without the arrhythmia in a previous study. The aim of th...
Saved in:
| Published in: | Europace (London, England) Vol. 22; no. 4; pp. 530 - 537 |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
England
Oxford University Press
01.04.2020
|
| Subjects: | |
| ISSN: | 1099-5129, 1532-2092, 1532-2092 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Abstract
Aims
Atrial fibrillation (AF) has been associated with reduced brain volume, cognitive impairment, and reduced cerebral blood flow. The causes of reduced cerebral blood flow in AF are unknown, but no reduction was seen in individuals without the arrhythmia in a previous study. The aim of this study was to test the hypothesis that brain perfusion, measured with magnetic resonance imaging (MRI), improves after cardioversion of AF to sinus rhythm (SR).
Methods and results
All patients undergoing elective cardioversion at our institution were invited to participate. A total of 44 individuals were included. Magnetic resonance imaging studies were done before and after cardioversion with both brain perfusion and cerebral blood flow measurements. However, 17 did not complete the second MRI as they had a recurrence of AF during the observation period (recurrent AF group), leaving 17 in the SR group and 10 in the AF group to complete both measurements. Brain perfusion increased after cardioversion to SR by 4.9 mL/100 g/min in the whole brain (P < 0.001) and by 5.6 mL/100 g/min in grey matter (P < 0.001). Cerebral blood flow increased by 58.6 mL/min (P < 0.05). Both brain perfusion and cerebral blood flow remained unchanged when cardioversion was unsuccessful.
Conclusion
In this study of individuals undergoing elective cardioversion for AF, restoration, and maintenance of SR for at least 10 weeks after was associated with an improvement of brain perfusion and cerebral blood flow measured by both arterial spin labelling and phase contrast MRI. In those individuals where cardioversion was unsuccessful, there was no change in perfusion or blood flow. |
|---|---|
| AbstractList | Atrial fibrillation (AF) has been associated with reduced brain volume, cognitive impairment, and reduced cerebral blood flow. The causes of reduced cerebral blood flow in AF are unknown, but no reduction was seen in individuals without the arrhythmia in a previous study. The aim of this study was to test the hypothesis that brain perfusion, measured with magnetic resonance imaging (MRI), improves after cardioversion of AF to sinus rhythm (SR).AIMSAtrial fibrillation (AF) has been associated with reduced brain volume, cognitive impairment, and reduced cerebral blood flow. The causes of reduced cerebral blood flow in AF are unknown, but no reduction was seen in individuals without the arrhythmia in a previous study. The aim of this study was to test the hypothesis that brain perfusion, measured with magnetic resonance imaging (MRI), improves after cardioversion of AF to sinus rhythm (SR).All patients undergoing elective cardioversion at our institution were invited to participate. A total of 44 individuals were included. Magnetic resonance imaging studies were done before and after cardioversion with both brain perfusion and cerebral blood flow measurements. However, 17 did not complete the second MRI as they had a recurrence of AF during the observation period (recurrent AF group), leaving 17 in the SR group and 10 in the AF group to complete both measurements. Brain perfusion increased after cardioversion to SR by 4.9 mL/100 g/min in the whole brain (P < 0.001) and by 5.6 mL/100 g/min in grey matter (P < 0.001). Cerebral blood flow increased by 58.6 mL/min (P < 0.05). Both brain perfusion and cerebral blood flow remained unchanged when cardioversion was unsuccessful.METHODS AND RESULTSAll patients undergoing elective cardioversion at our institution were invited to participate. A total of 44 individuals were included. Magnetic resonance imaging studies were done before and after cardioversion with both brain perfusion and cerebral blood flow measurements. However, 17 did not complete the second MRI as they had a recurrence of AF during the observation period (recurrent AF group), leaving 17 in the SR group and 10 in the AF group to complete both measurements. Brain perfusion increased after cardioversion to SR by 4.9 mL/100 g/min in the whole brain (P < 0.001) and by 5.6 mL/100 g/min in grey matter (P < 0.001). Cerebral blood flow increased by 58.6 mL/min (P < 0.05). Both brain perfusion and cerebral blood flow remained unchanged when cardioversion was unsuccessful.In this study of individuals undergoing elective cardioversion for AF, restoration, and maintenance of SR for at least 10 weeks after was associated with an improvement of brain perfusion and cerebral blood flow measured by both arterial spin labelling and phase contrast MRI. In those individuals where cardioversion was unsuccessful, there was no change in perfusion or blood flow.CONCLUSIONIn this study of individuals undergoing elective cardioversion for AF, restoration, and maintenance of SR for at least 10 weeks after was associated with an improvement of brain perfusion and cerebral blood flow measured by both arterial spin labelling and phase contrast MRI. In those individuals where cardioversion was unsuccessful, there was no change in perfusion or blood flow. Abstract Aims Atrial fibrillation (AF) has been associated with reduced brain volume, cognitive impairment, and reduced cerebral blood flow. The causes of reduced cerebral blood flow in AF are unknown, but no reduction was seen in individuals without the arrhythmia in a previous study. The aim of this study was to test the hypothesis that brain perfusion, measured with magnetic resonance imaging (MRI), improves after cardioversion of AF to sinus rhythm (SR). Methods and results All patients undergoing elective cardioversion at our institution were invited to participate. A total of 44 individuals were included. Magnetic resonance imaging studies were done before and after cardioversion with both brain perfusion and cerebral blood flow measurements. However, 17 did not complete the second MRI as they had a recurrence of AF during the observation period (recurrent AF group), leaving 17 in the SR group and 10 in the AF group to complete both measurements. Brain perfusion increased after cardioversion to SR by 4.9 mL/100 g/min in the whole brain (P < 0.001) and by 5.6 mL/100 g/min in grey matter (P < 0.001). Cerebral blood flow increased by 58.6 mL/min (P < 0.05). Both brain perfusion and cerebral blood flow remained unchanged when cardioversion was unsuccessful. Conclusion In this study of individuals undergoing elective cardioversion for AF, restoration, and maintenance of SR for at least 10 weeks after was associated with an improvement of brain perfusion and cerebral blood flow measured by both arterial spin labelling and phase contrast MRI. In those individuals where cardioversion was unsuccessful, there was no change in perfusion or blood flow. Atrial fibrillation (AF) has been associated with reduced brain volume, cognitive impairment, and reduced cerebral blood flow. The causes of reduced cerebral blood flow in AF are unknown, but no reduction was seen in individuals without the arrhythmia in a previous study. The aim of this study was to test the hypothesis that brain perfusion, measured with magnetic resonance imaging (MRI), improves after cardioversion of AF to sinus rhythm (SR). All patients undergoing elective cardioversion at our institution were invited to participate. A total of 44 individuals were included. Magnetic resonance imaging studies were done before and after cardioversion with both brain perfusion and cerebral blood flow measurements. However, 17 did not complete the second MRI as they had a recurrence of AF during the observation period (recurrent AF group), leaving 17 in the SR group and 10 in the AF group to complete both measurements. Brain perfusion increased after cardioversion to SR by 4.9 mL/100 g/min in the whole brain (P < 0.001) and by 5.6 mL/100 g/min in grey matter (P < 0.001). Cerebral blood flow increased by 58.6 mL/min (P < 0.05). Both brain perfusion and cerebral blood flow remained unchanged when cardioversion was unsuccessful. In this study of individuals undergoing elective cardioversion for AF, restoration, and maintenance of SR for at least 10 weeks after was associated with an improvement of brain perfusion and cerebral blood flow measured by both arterial spin labelling and phase contrast MRI. In those individuals where cardioversion was unsuccessful, there was no change in perfusion or blood flow. |
| Author | Gardarsdottir, Marianna Aspelund, Thor Arnar, David O Gardarsdottir, Valdis Anna Forsberg, Lars Sigurdsson, Sigurdur Gudnason, Vilmundur |
| AuthorAffiliation | 2 Icelandic Heart Association , Kopavogur, Iceland 3 Faculty of Medicine, School of Health Sciences, University of Iceland , Reykjavik, Iceland 4 Department of Medicine, Landspitali—The National University Hospital of Iceland , 14C, Hringbraut, 101 Reykjavik, Iceland 1 Department of Radiology, Landspitali—The National University Hospital of Iceland , Reykjavik, Iceland |
| AuthorAffiliation_xml | – name: 3 Faculty of Medicine, School of Health Sciences, University of Iceland , Reykjavik, Iceland – name: 4 Department of Medicine, Landspitali—The National University Hospital of Iceland , 14C, Hringbraut, 101 Reykjavik, Iceland – name: 1 Department of Radiology, Landspitali—The National University Hospital of Iceland , Reykjavik, Iceland – name: 2 Icelandic Heart Association , Kopavogur, Iceland |
| Author_xml | – sequence: 1 givenname: Marianna surname: Gardarsdottir fullname: Gardarsdottir, Marianna organization: Department of Radiology, Landspitali—The National University Hospital of Iceland, Reykjavik, Iceland – sequence: 2 givenname: Sigurdur surname: Sigurdsson fullname: Sigurdsson, Sigurdur organization: Icelandic Heart Association, Kopavogur, Iceland – sequence: 3 givenname: Thor surname: Aspelund fullname: Aspelund, Thor organization: Icelandic Heart Association, Kopavogur, Iceland – sequence: 4 givenname: Valdis Anna surname: Gardarsdottir fullname: Gardarsdottir, Valdis Anna organization: Department of Medicine, Landspitali—The National University Hospital of Iceland, 14C, Hringbraut, 101 Reykjavik, Iceland – sequence: 5 givenname: Lars surname: Forsberg fullname: Forsberg, Lars organization: Icelandic Heart Association, Kopavogur, Iceland – sequence: 6 givenname: Vilmundur surname: Gudnason fullname: Gudnason, Vilmundur organization: Icelandic Heart Association, Kopavogur, Iceland – sequence: 7 givenname: David O orcidid: 0000-0002-9442-1644 surname: Arnar fullname: Arnar, David O email: davidar@landspitali.is organization: Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31860069$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFUUtLxDAQDrKiu-rZm_QoQt082mxzEUR8LCx60XNI04lGuk1NWkF_vdkn6kEhMMPM95jMjNCgcQ0gdEzwOcGCjaH3rlUaYvLJGN9BQ5IzmlIs6CDmWIg0J1Tso1EIrxjjCRX5HtpnpOAYczFE99N56907VEnplW2SFrzpg3VNokwHPoEadOetVnWila9shPpl25lExUasG1t6W9eqi-VDtGtUHeBoHQ_Q083149VdOnu4nV5dzlKdiaxLKwBRGEZ4KWDxCi4UqYjGxGRlVaicKjDAeSxkE6PxIhDKaIV5ySAz7ABdrHTbvpxDpaHpvKpl6-1c-Q_plJU_O419kc_uXU4IoznjUeB0LeDdWw-hk3MbNMRvNOD6IKOZmNAiIwvoyXevrclmiREwXgG0dyF4MFsIwXJxJrk5k1ydKTLyXwxtu-UC47C2_oN3tuK5vv3X5Atuo60e |
| CitedBy_id | crossref_primary_10_1002_joa3_13056 crossref_primary_10_1055_a_2184_7506 crossref_primary_10_15420_aer_2022_29 crossref_primary_10_1016_j_jacep_2022_08_017 crossref_primary_10_1111_jce_16108 crossref_primary_10_1161_CIRCULATIONAHA_121_055018 crossref_primary_10_1093_eurheartj_ehaf040 crossref_primary_10_1016_j_cmpb_2024_108303 crossref_primary_10_1016_j_jacep_2022_07_011 crossref_primary_10_1093_ehjcvp_pvad021 crossref_primary_10_1002_ejhf_2122 crossref_primary_10_1007_s41999_021_00537_w crossref_primary_10_1155_2021_8852466 crossref_primary_10_3390_jcm12093050 crossref_primary_10_1016_j_ejim_2020_07_010 crossref_primary_10_1016_j_brainresbull_2025_111392 crossref_primary_10_1038_s41440_024_01662_2 crossref_primary_10_1097_CRD_0000000000000938 crossref_primary_10_3389_fcvm_2022_850968 crossref_primary_10_3389_fphys_2020_01066 crossref_primary_10_3390_jpm12040572 crossref_primary_10_1002_ctm2_1367 crossref_primary_10_1002_alz_13870 crossref_primary_10_1161_JAHA_123_033594 crossref_primary_10_3390_biomedicines12081931 crossref_primary_10_1016_j_hrthm_2024_04_038 crossref_primary_10_1016_j_pcad_2025_07_006 crossref_primary_10_3389_fcvm_2022_844275 crossref_primary_10_1016_j_ahj_2022_09_007 crossref_primary_10_3390_jcm13185581 crossref_primary_10_1097_HCO_0000000000001093 crossref_primary_10_1111_jce_16054 crossref_primary_10_9794_jspccs_40_193 crossref_primary_10_1016_j_ccep_2023_08_003 crossref_primary_10_26599_1671_5411_2023_09_003 crossref_primary_10_1161_CIRCULATIONAHA_120_045866 |
| Cites_doi | 10.1016/j.ccl.2015.12.011 10.1053/j.jvca.2012.04.016 10.1016/S1474-4422(11)70307-6 10.1093/eurheartj/ehy176 10.1002/mrm.22776 10.1093/europace/eux031 10.1161/CIRCULATIONAHA.117.027448 10.1016/j.neurobiolaging.2008.04.008 10.1093/europace/euw295 10.1038/jcbfm.1989.62 10.1111/j.1540-8159.2011.03277.x 10.1161/JAHA.116.005155 10.1016/j.hrthm.2009.12.004 10.1371/journal.pone.0144743 10.1161/STROKEAHA.12.679381 10.1093/europace/eux220 10.1016/j.clineuro.2007.06.001 10.1111/j.1540-8167.2011.02035.x 10.1093/europace/eut246 10.1016/j.cjca.2017.09.024 10.1016/j.neuroimage.2011.11.024 10.1148/radiol.2016150789 |
| ContentType | Journal Article |
| Copyright | Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2019. For permissions, please email: journals.permissions@oup.com. 2019 Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2019. For permissions, please email: journals.permissions@oup.com. |
| Copyright_xml | – notice: Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2019. For permissions, please email: journals.permissions@oup.com. 2019 – notice: Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2019. For permissions, please email: journals.permissions@oup.com. |
| DBID | AAYXX CITATION NPM 7X8 5PM |
| DOI | 10.1093/europace/euz336 |
| DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic PubMed |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1532-2092 |
| EndPage | 537 |
| ExternalDocumentID | PMC7132536 31860069 10_1093_europace_euz336 10.1093/europace/euz336 |
| Genre | Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: ; ; – fundername: ; ; grantid: N01-AG-1-2100 |
| GroupedDBID | --- .2P .I3 .XZ .ZR 0R~ 29G 2WC 4.4 48X 53G 5GY 5VS 5WA 6PF 70D AABZA AACZT AAJKP AAMVS AAOGV AAPNW AAPQZ AAPXW AASNB AAUAY AAUQX AAVAP AAWTL ABEUO ABIXL ABJNI ABKDP ABNHQ ABNKS ABPTD ABQLI ABWST ABXVV ABZBJ ACGFS ACPRK ACUFI ACUTO ADBBV ADEYI ADEZT ADGZP ADHKW ADHZD ADJQC ADOCK ADRIX ADRTK ADVEK ADYVW ADZXQ AEGPL AEJOX AEKSI AEMDU AENEX AENZO AEPUE AETBJ AEWNT AFFZL AFIYH AFOFC AFXAL AFXEN AGINJ AGKEF AGQXC AGSYK AGUTN AHMBA AHXPO AIJHB AJEEA ALMA_UNASSIGNED_HOLDINGS ALUQC APIBT APWMN ATGXG AXUDD BAWUL BAYMD BCRHZ BEYMZ BHONS BTRTY BVRKM CDBKE CS3 CZ4 DAKXR DIK DILTD DU5 D~K E3Z EBD EBS EE~ EMOBN ENERS F5P F9B FECEO FLUFQ FOEOM FOTVD FQBLK GAUVT GJXCC GX1 H13 H5~ HAR HW0 HZ~ IOX J21 KBUDW KOP KQ8 KSI KSN M-Z MHKGH N9A NGC NOMLY NOYVH O9- OAUYM OAWHX ODMLO OJQWA OJZSN OK1 OPAEJ P2P PAFKI PEELM PQQKQ Q1. Q5Y RD5 RHF ROL ROX RPM RUSNO RW1 RXO SEL SV3 TCURE TJX TOX TR2 VVN W8F WOQ X7H YAYTL YKOAZ YXANX ZKX ~91 AAYXX ABEJV ABGNP ABPQP ABVGC AEMQT ALXQX AMNDL CITATION JXSIZ NPM 7X8 5PM OVD |
| ID | FETCH-LOGICAL-c494t-dee98f316b9eb9eb869a1d1c01f4bd8a52aefe66c0147fc001471232d06b3e4f3 |
| IEDL.DBID | TOX |
| ISICitedReferencesCount | 43 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000536492700010&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1099-5129 1532-2092 |
| IngestDate | Tue Nov 04 02:00:11 EST 2025 Wed Oct 01 14:14:13 EDT 2025 Mon Jul 21 05:57:48 EDT 2025 Tue Nov 18 22:32:41 EST 2025 Sat Nov 29 05:18:57 EST 2025 Wed Aug 28 03:18:31 EDT 2024 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 4 |
| Keywords | Cardioversion Brain volume Brain perfusion Cerebral blood flow Atrial fibrillation Cognitive impairment |
| Language | English |
| License | This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model) https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2019. For permissions, please email: journals.permissions@oup.com. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c494t-dee98f316b9eb9eb869a1d1c01f4bd8a52aefe66c0147fc001471232d06b3e4f3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0000-0002-9442-1644 |
| OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/7132536 |
| PMID | 31860069 |
| PQID | 2329728416 |
| PQPubID | 23479 |
| PageCount | 8 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_7132536 proquest_miscellaneous_2329728416 pubmed_primary_31860069 crossref_primary_10_1093_europace_euz336 crossref_citationtrail_10_1093_europace_euz336 oup_primary_10_1093_europace_euz336 |
| PublicationCentury | 2000 |
| PublicationDate | 2020-04-01 |
| PublicationDateYYYYMMDD | 2020-04-01 |
| PublicationDate_xml | – month: 04 year: 2020 text: 2020-04-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England |
| PublicationTitle | Europace (London, England) |
| PublicationTitleAlternate | Europace |
| PublicationYear | 2020 |
| Publisher | Oxford University Press |
| Publisher_xml | – name: Oxford University Press |
| References | Kalantarian (2020040604553585100_euz336-B4) 2016; 34 Rivard (2020040604553585100_euz336-B19) 2017; 33 Bunch (2020040604553585100_euz336-B8) 2010; 7 Petersen (2020040604553585100_euz336-B12) 1989; 9 Elbers (2020040604553585100_euz336-B16) 2012; 26 Dietzel (2020040604553585100_euz336-B3) 2018; 20 Porebska (2020040604553585100_euz336-B14) 2007; 109 Haller (2020040604553585100_euz336-B17) 2016; 281 Bonekamp (2020040604553585100_euz336-B11) 2011; 66 Lane (2020040604553585100_euz336-B1) 2017; 6 Kirchhof (2020040604553585100_euz336-B18) 2018; 39 Gardarsdottir (2020040604553585100_euz336-B6) 2018; 20 Kirchhof (2020040604553585100_euz336-B2) 2016; 18 Wolters (2020040604553585100_euz336-B7) 2017; 136 Ikram (2020040604553585100_euz336-B22) 2010; 31 Wutzler (2020040604553585100_euz336-B15) 2014; 16 Stefansdottir (2020040604553585100_euz336-B5) 2013; 44 Sigurdsson (2020040604553585100_euz336-B10) 2015; 10 Bunch (2020040604553585100_euz336-B21) 2011; 22 Sigurdsson (2020040604553585100_euz336-B9) 2012; 59 Smith (2020040604553585100_euz336-B20) 2012; 11 Efimova (2020040604553585100_euz336-B13) 2012; 35 |
| References_xml | – volume: 34 start-page: 279 year: 2016 ident: 2020040604553585100_euz336-B4 article-title: Atrial fibrillation and cognitive decline: phenomenon or epiphenomenon? publication-title: Cardiol Clin doi: 10.1016/j.ccl.2015.12.011 – volume: 26 start-page: 799 year: 2012 ident: 2020040604553585100_euz336-B16 article-title: Electrical cardioversion for atrial fibrillation improves microvascular flow independent of blood pressure changes publication-title: J Cardiothorac Vasc Anesth doi: 10.1053/j.jvca.2012.04.016 – volume: 11 start-page: 272 year: 2012 ident: 2020040604553585100_euz336-B20 article-title: Cerebral microinfarcts: the invisible lesions publication-title: Lancet Neurol doi: 10.1016/S1474-4422(11)70307-6 – volume: 39 start-page: 2942 year: 2018 ident: 2020040604553585100_euz336-B18 article-title: Apixaban in patients at risk of stroke undergoing atrial fibrillation ablation publication-title: Eur Heart J doi: 10.1093/eurheartj/ehy176 – volume: 66 start-page: 57 year: 2011 ident: 2020040604553585100_euz336-B11 article-title: Quantitative cerebral blood flow in dynamic susceptibility contrast MRI using total cerebral flow from phase contrast magnetic resonance angiography publication-title: Magn Reson Med doi: 10.1002/mrm.22776 – volume: 20 start-page: 408 year: 2018 ident: 2020040604553585100_euz336-B3 article-title: Does atrial fibrillation cause cognitive decline and dementia? publication-title: Europace doi: 10.1093/europace/eux031 – volume: 136 start-page: 719 year: 2017 ident: 2020040604553585100_euz336-B7 article-title: Cerebral perfusion and the risk of dementia: a population-based study publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.117.027448 – volume: 31 start-page: 378 year: 2010 ident: 2020040604553585100_euz336-B22 article-title: Brain tissue volumes in relation to cognitive function and risk of dementia publication-title: Neurobiol Aging doi: 10.1016/j.neurobiolaging.2008.04.008 – volume: 18 start-page: 1609 year: 2016 ident: 2020040604553585100_euz336-B2 article-title: 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS publication-title: Europace doi: 10.1093/europace/euw295 – volume: 9 start-page: 422 year: 1989 ident: 2020040604553585100_euz336-B12 article-title: Cerebral blood flow before and after cardioversion of atrial fibrillation publication-title: J Cereb Blood Flow Metab doi: 10.1038/jcbfm.1989.62 – volume: 35 start-page: 320 year: 2012 ident: 2020040604553585100_euz336-B13 article-title: Ablation and pacing: improving brain perfusion and cognitive function in patients with atrial fibrillation and uncontrolled ventricular rates publication-title: Pacing Clin Electrophysiol doi: 10.1111/j.1540-8159.2011.03277.x – volume: 6 year: 2017 ident: 2020040604553585100_euz336-B1 article-title: Temporal trends in incidence, prevalence, and mortality of atrial fibrillation in primary care publication-title: J Am Heart Assoc doi: 10.1161/JAHA.116.005155 – volume: 7 start-page: 433 year: 2010 ident: 2020040604553585100_euz336-B8 article-title: Atrial fibrillation is independently associated with senile, vascular, and Alzheimer's dementia publication-title: Heart Rhythm doi: 10.1016/j.hrthm.2009.12.004 – volume: 10 start-page: e0144743. year: 2015 ident: 2020040604553585100_euz336-B10 article-title: Feasibility of using pseudo-continuous arterial spin labeling perfusion in a geriatric population at 1.5 tesla publication-title: PLoS One doi: 10.1371/journal.pone.0144743 – volume: 44 start-page: 1020 year: 2013 ident: 2020040604553585100_euz336-B5 article-title: Atrial fibrillation is associated with reduced brain volume and cognitive function independent of cerebral infarcts publication-title: Stroke doi: 10.1161/STROKEAHA.12.679381 – volume: 20 start-page: 1252 year: 2018 ident: 2020040604553585100_euz336-B6 article-title: Atrial fibrillation is associated with decreased total cerebral blood flow and brain perfusion publication-title: Europace doi: 10.1093/europace/eux220 – volume: 109 start-page: 753 year: 2007 ident: 2020040604553585100_euz336-B14 article-title: Nonembolic, hemodynamic blood flow disturbances in the middle cerebral arteries in patients with paroxysmal atrial fibrillation without significant carotid stenosis publication-title: Clin Neurol Neurosurg doi: 10.1016/j.clineuro.2007.06.001 – volume: 22 start-page: 839 year: 2011 ident: 2020040604553585100_euz336-B21 article-title: Patients treated with catheter ablation for atrial fibrillation have long-term rates of death, stroke, and dementia similar to patients without atrial fibrillation publication-title: J Cardiovasc Electrophysiol doi: 10.1111/j.1540-8167.2011.02035.x – volume: 16 start-page: 189 year: 2014 ident: 2020040604553585100_euz336-B15 article-title: Improvement of cerebral oxygen saturation after successful electrical cardioversion of atrial fibrillation publication-title: Europace doi: 10.1093/europace/eut246 – volume: 33 start-page: 1556 year: 2017 ident: 2020040604553585100_euz336-B19 article-title: Mechanisms, clinical significance, and prevention of cognitive impairment in patients with atrial fibrillation publication-title: Can J Cardiol doi: 10.1016/j.cjca.2017.09.024 – volume: 59 start-page: 3862 year: 2012 ident: 2020040604553585100_euz336-B9 article-title: Brain tissue volumes in the general population of the elderly: the AGES-Reykjavik study publication-title: Neuroimage doi: 10.1016/j.neuroimage.2011.11.024 – volume: 281 start-page: 337 year: 2016 ident: 2020040604553585100_euz336-B17 article-title: Arterial spin labeling perfusion of the brain: emerging clinical applications publication-title: Radiology doi: 10.1148/radiol.2016150789 |
| SSID | ssj0007295 |
| Score | 2.4640293 |
| Snippet | Abstract
Aims
Atrial fibrillation (AF) has been associated with reduced brain volume, cognitive impairment, and reduced cerebral blood flow. The causes of... Atrial fibrillation (AF) has been associated with reduced brain volume, cognitive impairment, and reduced cerebral blood flow. The causes of reduced cerebral... |
| SourceID | pubmedcentral proquest pubmed crossref oup |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 530 |
| SubjectTerms | Clinical Research |
| Title | Improved brain perfusion after electrical cardioversion of atrial fibrillation |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/31860069 https://www.proquest.com/docview/2329728416 https://pubmed.ncbi.nlm.nih.gov/PMC7132536 |
| Volume | 22 |
| WOSCitedRecordID | wos000536492700010&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVASL databaseName: Oxford Journals Open Access Collection customDbUrl: eissn: 1532-2092 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0007295 issn: 1099-5129 databaseCode: TOX dateStart: 19990101 isFulltext: true titleUrlDefault: https://academic.oup.com/journals/ providerName: Oxford University Press |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3JTsMwEB1BhRAX9qUslREcuASSOJuPCFFxgMKhoN6i2JmISlVadeHA1-OJ06hhESDlECW25Xgc-41n5g3AuUo17Ii4sqTkgeWlIbeSxOaWtNHnqDF0WkTIvdyHnU7U64mnkiZn8o0JX_ArIqnQ-iPqm3fOiV3b8SOa0t3HXrXoaozoF4ZNISzaw-YsPl_r1zagWlDbArb87CK5sOe0N_7T201YL5EluzZTYQuWMN-G1YfSdr4DHXN-gCmTlBaCjXCczeisjBV5wplJiEMyY8o4qZqjNDbMWFIk92AZxQcMjPfcLjy3b7s3d1aZTcFSnvCmVooooow7gRRIVxSIxEkdZTuZJ9Mo8d0EMwwC_cALM0W6U0h4K7UDydHL-B408mGOB8BcX-mWXNRwI_QQlUCtF3GtGEmlpO0lTbicD3GsSqpxyngxiI3Jm8fzUYrNKDXhoqowMiwbPxc90zL7vdTpXKax_l_ICJLkOJxNYv1FInTJ2NqEfSPjqjG9vgVE3dyEsCb9qgBxcdff5P3XgpNb6_quz4PDP_XuCNZcUtsLB6BjaEzHMzyBFfU27U_GLVgOe1GrmN4faEb_BA |
| linkProvider | Oxford University Press |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Improved+brain+perfusion+after+electrical+cardioversion+of+atrial+fibrillation&rft.jtitle=Europace+%28London%2C+England%29&rft.au=Gardarsdottir%2C+Marianna&rft.au=Sigurdsson%2C+Sigurdur&rft.au=Aspelund%2C+Thor&rft.au=Gardarsdottir%2C+Valdis+Anna&rft.date=2020-04-01&rft.pub=Oxford+University+Press&rft.issn=1099-5129&rft.eissn=1532-2092&rft.volume=22&rft.issue=4&rft.spage=530&rft.epage=537&rft_id=info:doi/10.1093%2Feuropace%2Feuz336&rft.externalDocID=10.1093%2Feuropace%2Feuz336 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1099-5129&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1099-5129&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1099-5129&client=summon |